II
ALXN
Inspire Investing’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-19,395
| Closed | -$3.56M | – | 974 |
|
|
2021
Q2 | $3.56M | Buy |
19,395
+1,300
| +7% | +$239K | 0.47% | 39 |
|
|
2021
Q1 | $2.77M | Buy |
18,095
+4,092
| +29% | +$626K | 0.42% | 46 |
|
|
2020
Q4 | $2.19M | Buy |
14,003
+1,301
| +10% | +$203K | 0.48% | 32 |
|
|
2020
Q3 | $1.45M | Buy |
12,702
+1,177
| +10% | +$135K | 0.4% | 49 |
|
|
2020
Q2 | $1.29M | Buy |
11,525
+3,147
| +38% | +$353K | 0.45% | 43 |
|
|
2020
Q1 | $752K | Sell |
8,378
-1,720
| -17% | -$154K | 0.3% | 55 |
|
|
2019
Q4 | $1.09M | Buy |
10,098
+979
| +11% | +$106K | 0.39% | 59 |
|
|
2019
Q3 | $893K | Buy |
9,119
+1,478
| +19% | +$145K | 0.34% | 68 |
|
|
2019
Q2 | $1M | Buy |
7,641
+719
| +10% | +$94.2K | 0.42% | 45 |
|
|
2019
Q1 | $936K | Buy |
6,922
+1,118
| +19% | +$151K | 0.43% | 41 |
|
|
2018
Q4 | $565K | Buy |
5,804
+633
| +12% | +$61.6K | 0.38% | 54 |
|
|
2018
Q3 | $719K | Buy |
5,171
+820
| +19% | +$114K | 0.44% | 37 |
|
|
2018
Q2 | $540K | Buy |
4,351
+2,168
| +99% | +$269K | 0.38% | 47 |
|
|
2018
Q1 | $243K | Buy |
2,183
+491
| +29% | +$54.7K | 0.25% | 136 |
|
|
2017
Q4 | $202K | Buy |
+1,692
| New | +$202K | 0.17% | 74 |
|